News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,501 Results
Type
Article (41193)
Company Profile (270)
Press Release (668038)
Section
Business (208246)
Career Advice (2082)
Deals (36009)
Drug Delivery (95)
Drug Development (81535)
Employer Resources (170)
FDA (16516)
Job Trends (15200)
News (351075)
Policy (33005)
Tag
Academia (2619)
Alliances (50857)
Alzheimer's disease (1329)
Approvals (16501)
Artificial intelligence (218)
Bankruptcy (359)
Best Places to Work (11944)
Biotechnology (187)
Breast cancer (237)
Cancer (1795)
Cardiovascular disease (133)
Career advice (1735)
CAR-T (131)
Cell therapy (375)
Clinical research (65767)
Collaboration (713)
Compensation (383)
COVID-19 (2606)
C-suite (177)
Data (1712)
Diabetes (222)
Diagnostics (6496)
Earnings (86716)
Employer resources (146)
Events (113731)
Executive appointments (607)
FDA (17500)
Funding (642)
Gene therapy (259)
GLP-1 (667)
Government (4428)
Healthcare (19361)
Infectious disease (2727)
Inflammatory bowel disease (127)
Interviews (328)
IPO (16689)
Job creations (3698)
Job search strategy (1468)
Layoffs (441)
Legal (8005)
Lung cancer (260)
Manufacturing (247)
Medical device (13833)
Medtech (13838)
Mergers & acquisitions (19728)
Metabolic disorders (579)
Neuroscience (1756)
NextGen: Class of 2025 (6776)
Non-profit (4576)
Northern California (2218)
Obesity (318)
Opinion (199)
Patents (178)
People (58114)
Phase I (20487)
Phase II (28969)
Phase III (21563)
Pipeline (801)
Postmarket research (2584)
Preclinical (8678)
Radiopharmaceuticals (246)
Rare diseases (336)
Real estate (6070)
Regulatory (22360)
Research institute (2393)
Resumes & cover letters (362)
Southern California (1900)
Startups (3639)
United States (19630)
Vaccines (632)
Weight loss (217)
Date
Today (218)
Last 7 days (855)
Last 30 days (2928)
Last 365 days (34946)
2025 (5638)
2024 (35819)
2023 (40719)
2022 (51909)
2021 (56548)
2020 (55219)
2019 (48042)
2018 (36226)
2017 (32890)
2016 (32392)
2015 (38432)
2014 (32080)
2013 (27125)
2012 (29377)
2011 (30003)
2010 (28010)
Location
Africa (741)
Arizona (212)
Asia (38633)
Australia (6305)
California (5054)
Canada (1771)
China (420)
Colorado (235)
Connecticut (242)
Europe (84200)
Florida (746)
Georgia (183)
Illinois (485)
Indiana (277)
Maryland (775)
Massachusetts (3873)
Michigan (219)
Minnesota (356)
New Jersey (1429)
New York (1444)
North Carolina (897)
Northern California (2218)
Ohio (183)
Pennsylvania (1143)
South America (1139)
Southern California (1900)
Texas (738)
Utah (160)
Washington State (484)
709,501 Results for "bone solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
February 25, 2025
·
10 min read
Business
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended March 31, 2024.
May 6, 2024
·
8 min read
Obesity
Amgen Suffers Surprise Blow as New Bone Density Safety Concerns for MariTide Surface
Cantor Fitzgerald analyst Olivia Brayer found supplementary bone mineral density data for Amgen’s obesity candidate MariTide that could point to a potentially greater fracture risk than previously revealed, but some other analysts view the findings as a nonissue.
November 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
November 13, 2024
·
9 min read
Drug Development
BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children’s Bone Health
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the presentation of new data from an investigator-led analysis of the Phase 2 111-205 study, which demonstrate that children with achondroplasia treated with VOXZOGO® experienced increases in bone length while maintaining bone strength.
June 17, 2024
·
13 min read
Press Releases
Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use
September 24, 2024
·
3 min read
Lone Star Bio
Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures
Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today 510(k) clearance of Mg OSTEOCRETE from the U.S. Food and Drug Administration (FDA) for use in the intervertebral body disc space, including cervical, thoracic, and lumbar fusion procedures.
February 13, 2024
·
2 min read
Press Releases
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
February 3, 2025
·
1 min read
Press Releases
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
October 10, 2024
·
2 min read
Genetown
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
Bone Biologics Corporation announces that the first two patients have been treated in the multicenter, prospective, randomized pilot clinical study of the Company’s NB1 bone graft device.
June 20, 2024
·
5 min read
1 of 70,951
Next
